Vaccine coagulation disorders

Last updated on: 27.01.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Patients with coagulation disorders or bleeding tendencies can almost always be vaccinated subcutaneously (s.c.). The s.c. application is covered by the approval for most vaccines or another vaccine against the corresponding pathogen with s.c. approval can be found. If there is no approval for s.c. administration, vaccination may also be administered intramuscularly (i.m.) with a very fine injection needle and subsequent firm compression of the injection site for at least 2 minutes, if an individual risk-benefit assessment is in favour of vaccination.[1].

The following table provides information on the recommended or prescribed route of injection according to pathogen, as well as further information on injections in the case of coagulation disorders or bleeding tendency from the respective expert information for all vaccines currently available in Germany. If indicated in the SmPC, alternative injection routes are also listed. No indication in the field "Alternative route of injection" means that there is no information on this in the respective SmPC.

LiteratureThis section has been translated automatically.

  1. Communication of the Robert Koch Institute (retrieved on 25.1.2021).

Last updated on: 27.01.2021